Jiangsu Hengrui Pharmaceuticals Co.,Ltd Share Price
Stocks
600276
CNE0000014W7
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.19 CNY | -5.00% |
|
-4.59% | -10.71% |
| 17/07 | Hengrui Pharma Gets China Clinical Trial Nod for Osteoarthritis Injection; Shares Fall 4% | MT |
| 16/07 | Hengrui Pharma Wins China Nod for Stroke Drug Clinical Trial | MT |
| Market Cap | 35TCr 5.17TCr 4.52TCr 4.17TCr 3.85TCr 7.25TCr 4,98200Cr 7.41TCr 50TCr 20TCr 2,44000Cr 19TCr 19TCr 8,39900Cr | P/E 2026 * |
38.1x | P/E 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 31TCr 4.52TCr 3.95TCr 3.64TCr 3.36TCr 6.33TCr 4,34800Cr 6.47TCr 44TCr 17TCr 2,13000Cr 17TCr 17TCr 7,33200Cr | EV / Sales 2026 * |
8.57x | EV / Sales 2027 * | 7.22x |
| Free-Float |
51.65% | Yield 2026 * |
0.5% | Yield 2027 * | 0.57% |
| 1 day | -5.00% | ||
| 1 week | -4.59% | ||
| Current month | +2.21% | ||
| 1 month | +9.85% | ||
| 3 months | -5.57% | ||
| 6 months | -14.13% | ||
| Current year | -10.71% |
| 1 week | 53.02 |  | 58 |
| 1 month | 47.3 | | 58 |
| Current year | 45.26 | | 65.83 |
| 1 year | 45.26 | | 74.04 |
| 3 years | 35.51 | | 74.04 |
| 5 years | 27 | | 74.04 |
| 10 years | 15.51 | | 97.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Jun Liu
DFI | Director of Finance/CFO | 49 | 19/11/2021 |
Ji Feng
PSD | President | 55 | 02/04/2025 |
Yu Xu
CMP | Compliance Officer | 34 | 01/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Jie Ping Sun
BRD | Director/Board Member | 56 | 16/01/2020 |
Hong Bin Dai
BRD | Director/Board Member | 49 | 16/01/2020 |
Piao Yang Sun
CHM | Chairman | 67 | 08/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/03/26 | Other | Chairperson | 75,000 | 0.0290% | ||
| 25/03/26 | Other | Director | 49,000 | 0.0190% | ||
| 08/11/25 | Other | Chairperson | 1,20,000 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.00% | -4.59% | -9.48% | +12.69% | 5.17TCr | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,05100Cr | |
| +1.23% | -1.53% | +54.58% | +59.08% | 61TCr | |
| +0.04% | +2.58% | +34.47% | +86.33% | 45TCr | |
| +0.78% | -0.71% | +29.28% | +24.10% | 33TCr | |
| +1.41% | +0.58% | +35.44% | +40.67% | 28TCr | |
| -0.27% | -1.87% | +22.34% | +22.51% | 26TCr | |
| -1.76% | +2.37% | -20.43% | -38.00% | 22TCr | |
| -1.42% | +0.80% | +24.27% | +57.50% | 20TCr | |
| -1.48% | +3.43% | +24.08% | +71.67% | 17TCr | |
| Average | -0.56% | +0.03% | +24.73% | +49.79% | 36.27TCr | |
| Weighted average by Cap. | +0.29% | -0.04% | +36.84% | +78.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.57TCr 526.88Cr 460.44Cr 424.88Cr 391.63Cr 738.16Cr 51TCr 754.54Cr 5.08TCr 2TCr 25TCr 1.98TCr 1.94TCr 86TCr | 4.15TCr 612.28Cr 535.07Cr 493.75Cr 455.11Cr 857.8Cr 59TCr 876.85Cr 5.9TCr 2.32TCr 29TCr 2.3TCr 2.25TCr 99TCr |
| Net income | 871.01Cr 128.5Cr 112.3Cr 103.62Cr 96Cr 180.03Cr 12TCr 184.03Cr 1.24TCr 487.16Cr 6.06TCr 482.59Cr 472Cr 21TCr | 1.07TCr 158Cr 138.08Cr 127.41Cr 117.44Cr 221.36Cr 15TCr 226.27Cr 1.52TCr 599Cr 7.45TCr 593.38Cr 580.36Cr 26TCr |
| Net Debt | -4.46TCr -657.7Cr -574.76Cr -530.37Cr -488.87Cr -921.44Cr -63TCr -941.89Cr -6.34TCr -2.49TCr -31TCr -2.47TCr -2.42TCr -1,06800Cr | -5.08TCr -750.02Cr -655.44Cr -604.82Cr -557.5Cr -1.05TCr -72TCr -1.07TCr -7.23TCr -2.84TCr -35TCr -2.82TCr -2.75TCr -1,21800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CN¥53.19 | -5.00% | 11,61,81,697 |
| 16/26/16 | CN¥55.99 | -2.63% | 12,20,08,374 |
| 15/26/15 | CN¥57.50 | +4.89% | 19,41,69,673 |
| 14/26/14 | CN¥54.82 | -1.67% | 9,66,29,185 |
| 13/26/13 | CN¥55.75 | 0.00% | 9,30,29,343 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600276 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition